Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News CorMedix Inc CRMD

Healthcare
CorMedix Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. The Company is focused on commercializing its lead product DefenCath, which is an antimicrobial catheter lock solution approved to reduce the incidence of catheter-related bloodstream infections... see more

Recent & Breaking News (NDAQ:CRMD)

Cormedix Inc. Announces Resignation of Member of Its Board of Directors

Accesswire January 16, 2019

Mid-Day Market Update: Crude Oil Up 3%; Bio-Path Holdings Shares Plummet

Benzinga.com  January 15, 2019

Cormedix Announces Closing of $7.5 Million Senior Secured Convertible Debt Financing

Accesswire January 3, 2019

Cormedix Receives Approval to Sell $5.4 Million of NOL Tax Benefits Through the New Jersey Economic Development Authority Program

Accesswire December 10, 2018

CorMedix Exec VP of Tech Operations Armstrong Buys 250,000 @ Avg Price: $1.45

Benzinga.com  November 30, 2018

Cormedix Inc. Reports Third Quarter Financial Results and Provides Business Update

Accesswire November 14, 2018

CorMedix Inc. to Report Third Quarter 2018 Financial Results on Wednesday, November 14

Accesswire November 6, 2018

Data Projects the Global Medical Device Technologies Market to Grow $674 Billion by 2022

PR Newswire October 30, 2018

CorMedix Inc. Clarifies That No New Shares Are Being Issued In Connection With Its Recently Filed Form S-3 Registration Statement

Accesswire October 18, 2018

48 Biggest Movers From Yesterday

Benzinga.com  October 17, 2018

CorMedix Announces NYSE American Acceptance of Plan to Regain Listing Compliance

Accesswire August 31, 2018

CorMedix Inc. to Present at The 20th Annual Rodman & Renshaw Global Investment Conference

Accesswire August 30, 2018

Cormedix Inc. Reports Second Quarter Financial Results and Provides Business Update

Accesswire August 14, 2018

CorMedix Inc. to Report Second Quarter 2018 Financial Results on Tuesday, August 14

Accesswire August 2, 2018

Cormedix Inc. Announces Positive Results Of Its Neutrolin(R) Phase 3 Lock-It-100 Study Based On Recommendation By Independent Data Safety Monitoring Board

Accesswire July 25, 2018

Cormedix Inc. Completes Review and Source Verification of Phase 3 Lock-It 100 Data For Neutrolin(R)

Accesswire June 20, 2018

Cormedix Inc. Receives a Continued Listing Standard Notice from the NYSE American

Accesswire June 19, 2018

CorMedix, Inc. Reports Progress on LOCK- IT 100 Data Review and Appoints Paul Chew as Consultant Advisor CMO

Accesswire May 29, 2018

Cormedix Inc. Reports First Quarter Financial Results and Provides Business Update

Accesswire May 15, 2018

CorMedix Inc. to Report First Quarter 2018 Financial Results on Tuesday, May 15

Accesswire May 9, 2018